News
TWST
118.57
-5.36%
-6.72
Twist Bioscience Director Makes Eye-Catching Insider Move
TipRanks · 1h ago
Alger Small Cap Growth Fund Q2 2026 Portfolio Review
Seeking Alpha · 18h ago
Why Is Cathie Wood Betting on This Cloud Security Stock?
TipRanks · 1d ago
Twist Bioscience (TWST) Q3 2026 Earnings Call Transcript
The Motley Fool · 4d ago
Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News
Seeking Alpha · 4d ago
Weekly Report: what happened at TWST last week (0803-0807)?
Weekly Report · 4d ago
Cathie Wood loads up SpaceX, AI infra names, continues trimming Roblox, Palantir
Seeking Alpha · 4d ago
Twist Bioscience (TWST) Is Up 26.3% After Equity Raise And Guidance Hike Has The Bull Case Changed?
Simply Wall St · 4d ago
Twist Bioscience (TWST) Could Be 25% Overvalued Following Higher Revenue Guidance
Simply Wall St · 6d ago
Artisan Global Discovery Fund Q2 2026 Portfolio Activity
Seeking Alpha · 08/06 18:41
Earnings Update: Here's Why Analysts Just Lifted Their Twist Bioscience Corporation (NASDAQ:TWST) Price Target To US$104
Simply Wall St · 08/06 12:00
Cathie Wood’s ARK buys $23M SpaceX, $17M Nvidia; offloads Roblox, Palantir
Seeking Alpha · 08/06 06:03
Twist Bioscience Completes Upsized Public Equity Offering
TipRanks · 08/05 22:22
Twist Bioscience Is Maintained at Overweight by Piper Sandler
Dow Jones · 08/05 16:07
Twist Bioscience Price Target Raised to $115.00/Share From $85.00 by Piper Sandler
Dow Jones · 08/05 16:07
Piper Sandler Maintains Overweight on Twist Bioscience, Raises Price Target to $115
Benzinga · 08/05 15:57
Twist Biosciences: Accelerating Growth, Diminishing Margin Of Safety
Seeking Alpha · 08/05 14:08
The BioRevolution Has Accelerated
Seeking Alpha · 08/05 12:20
Twist Bioscience price target raised to $115 from $85 at Piper Sandler
TipRanks · 08/05 11:25
Twist Bioscience 3.125M share Spot Secondary priced at $96.00
TipRanks · 08/05 10:26
More
Webull provides a variety of real-time TWST stock news. You can receive the latest news about Twist Bioscience through multiple platforms. This information may help you make smarter investment decisions.
About TWST
Twist Bioscience Corporation provides customizable solutions across the biological continuum that enable scientific discovery and development across therapeutics, diagnostics, and other high-growth markets. The Company's proprietary silicon-based platform delivers precision, scale, and speed, supporting consistent, high-quality performance across a range of applications. The Company’s platform is a differentiated method of manufacturing synthetic deoxyribonucleic acid (DNA) by writing DNA on a silicon chip. By integrating proprietary hardware, software, and scalable infrastructure, including its e-commerce platform. The Company has extended this platform beyond DNA synthesis to offer an integrated portfolio that includes synthetic genes, next-generation sequencing, applications, sample preparation tools, antibody libraries, and biologic discovery services. Leveraging the same platform, it also manufactures synthetic ribonucleic acid (RNA) and expresses antibody proteins.